Zenapax and Methotrexate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zenapax (daclizumab) and Methotrexate (methotrexate sodium). Common drug interactions include sleep disorder due to general medical condition, insomnia type among females and bacterial sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Zenapax and Methotrexate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Zenapax?

Zenapax has active ingredients of daclizumab. eHealthMe is studying from 1,314 Zenapax users. Check the latest studies of Zenapax.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,313 Methotrexate users. Check the latest studies of Methotrexate.

On Aug, 12, 2026

14 people who take Zenapax and Methotrexate together, and have interactions are studied.

Zenapax and Methotrexate drug interactions.

What are the common drug interactions of Zenapax and Methotrexate, by gender? *:

female:

Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
Transplant rejection (a transplant material is not worked)
Acute hepatic failure
Drug level decreased
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Drug ineffective
Acne (skin problems that cause pimples)
Alopecia (absence of hair from areas of the body)
Ovarian cyst (fluid filled sac of the ovary)
Overdose

male:

Bacterial sepsis
Gastrointestinal toxicity (damage to digestive tract by any substance)
Hepatotoxicity (chemical-driven liver damage)

What are the common drug interactions of Zenapax and Methotrexate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Acute hepatic failure
Bacterial sepsis
Gastrointestinal toxicity (damage to digestive tract by any substance)
Hepatotoxicity (chemical-driven liver damage)

10-19:

Drug level decreased
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

20-29:

Drug ineffective

30-39:

n/a

40-49:

Acne (skin problems that cause pimples)
Alopecia (absence of hair from areas of the body)
Drug ineffective
Ovarian cyst (fluid filled sac of the ovary)
Overdose
Pain
Pneumonia
Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
Transplant rejection (a transplant material is not worked)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 4 people, 28.57%
Transplant Rejection (a transplant material is not worked): 2 people, 14.29%
Strongyloidiasis (infection with strongyloides stercoralis): 2 people, 14.29%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 2 people, 14.29%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Zenapax and Methotrexate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously